banner
banner

Partners

banner
 
 

Artikel Bebas

Article in English
Pregnancy and Hepatitis B (Evangeline Wang) Print E-mail

Source : https://www.hepb.org/blog/

Date : Februari 24, 2021. Hepatitis B Foundation

Author : Evangeline Wang, Program Coordinator

Contact Information: This e-mail address is being protected from spambots, you need JavaScript enabled to view it

The hepatitis B virus can cause an acute (lasting less than 6 months) or chronic (lifetime) infection. Chronic infection occurs in 90% of infants infected through mother-to-child transmission at birth; and about 50% of children will develop a chronic infection if exposed to the virus between 1 and 5 years of age. Those infected as adults are much less likely (<5%) to develop a chronic infection. Left untreated, hepatitis B can progress to cirrhosis and other serious liver diseases like liver cancer. This blog will talk about mother-to-child (perinatal) transmission and commonly asked questions about perinatal transmission.

Read more...
 
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant (Sarah Schillie, MD1; Aaron Harris, MD1; Ruth Link-Gelles, PhD1; José Romero, MD2; John Ward, MD1; Noele Nelson, MD1) Print E-mail
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant

Author : Sarah Schillie, MD1; Aaron Harris, MD1; Ruth Link-Gelles, PhD1; José Romero, MD2; John Ward, MD1; Noele Nelson, MD1

Source : Morbidity and Mortality Weekly Report,  April 20, 2018 / Vol. 67 / No. 15

Read more...
 
Hepatitis B Update (reflection) Print E-mail

ReFlections Vol 44, May 4, 2018. RGA (Reinsurance Group of America, Incorporated®)

Author : Akhilesh Pandey Senior Underwriter, Research and Manual Development. RGA India.

Abstract :

Hepatitis B is one of the world’s most prevalent infectious diseases  today. The disease has been recognized for millennia, but the first actual breakthrough in understanding its etiology came more than 50 years  ago, when it was discovered that the serum protein Australia Antigen  (first discovered in Australian Aborigines) was in fact the surface antigen (HBsAg) of the hepatitis B virus (HBV). This discovery enabled the development of a successful hepatitis B vaccine in 1981.1

Read more...
 
More Articles...
« StartPrev123456789NextEnd »

Page 1 of 9

Berbagi Bersama Kami

banner

Partners

Media Sosial

 

Visitor Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterHari ini227
mod_vvisit_counterKemarin504
mod_vvisit_counterMinggu Ini227
mod_vvisit_counterBulan Ini5540